Eli Lilly’s obesity drug Zepbound is now covered by Medicare for sleep apnea treatment, expanding access to the costly ...
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 484.89% and ...
In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...
Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...
Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...
New anti-obesity drugs should meet a minimum level of weight loss to be considered for approval, the FDA said ...
Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...
The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...
What does the latest science say about the use of GLP-1 meds to treat obesity in people without diabetes?A review of 26 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback